Schizophrenia
Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
CompletedNCT02176044
Official study titleThe Effect of Nitric Oxide on Spatial Working Memory in Patients With Schizophrenia - Pilot Study
This study has finished and is no longer accepting participants.
In LondonSchizophreniaMedication studyAges 18–60
- Countries
- United Kingdom
- Sponsor
- King's College London (University)
CompletedNCT04822051
Official study titleThe Effect of Psychoeducation Based On Uncertainty In Illness Theory On Intolerance To Uncertainty, Psychological Wellbeing And Coping Styles In Schizophrenia Caregivers
This study has finished and is no longer accepting participants.
In AntalyaSchizophreniaInterventional studyAges 18+
- Countries
- Türkiye
- Sponsor
- Akdeniz University
WithdrawnNCT03736291
Official study titleThe Effect of Repetitive Transcranial Magnetic Stimulation in Schizophrenia--A Randomized , Double-blind fMRI Study
This study was withdrawn before enrollment.
Location not clearly listedSchizophreniaDevice studyAges 18–55
- Countries
- Sponsor
- Shanghai Mental Health Center
TerminatedNCT02021201
Official study titleThe Effect of Sertindole and Risperidone on Endophenotypic Markers of Schizophrenia, a Comparative Study
This study ended early.
In Glostrup MunicipalitySchizophreniaMedication studyAges 18–55
- Countries
- Denmark
- Sponsor
- Birte Glenthoj
CompletedNCT02187692
Official study titleThe Effectiveness of The Meta-cognitive Training Among Chronic Schizophrenia Patients Treated Within Community Support Groups in Poland.
This study has finished and is no longer accepting participants.
In WarsawSchizophreniaBehavioural studyAges 18–65
- Countries
- Poland
- Sponsor
- Medical University of Warsaw
TerminatedNCT00209027
Official study titleAripiprazole Effects on Reward Processing in Deficit Syndrome Schizophrenia
This study ended early.
In DecaturSchizophreniaMedication studyAges 20–50
- Countries
- United States
- Sponsor
- Emory University
TerminatedNCT00548327
Official study titleRandomized, Double-Blinded, Placebo Controlled Study of the Effects of Atomoxetine on Cognitive Function in Patients With Schizophrenia and Normal Controls Based on COMT Genotype
This study ended early.
In BethesdaSchizophreniaMedication studyAges 18–45
- Countries
- United States
- Sponsor
- National Institute of Mental Health (NIMH) (Government agency)
TerminatedNCT01832766
This study ended early.
In AuroraSchizophreniaMedication studyAges 18–50
- Countries
- United States
- Sponsor
- University of Colorado, Denver
CompletedNCT03953664
Official study titleThe Effects of Three Different Modalities of Exercise Training (Aerobic, Strength, Aerobic-strength) on Psychological and Physiological Correlates in Schizophrenia: a Randomized Clinical Trial
This study has finished and is no longer accepting participants.
In MoncadaSchizophreniaInterventional studyAges 18–65
- Countries
- Spain
- Sponsor
- Cardenal Herrera University
TerminatedNCT01874756
Official study titleThe Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
This study ended early.
In IndianapolisSchizophreniaMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Indiana University
CompletedNCT02142556
What is this study about?Researchers studied Administration of quetiapine XR, tracking side effects to assess safety and tolerability in people with schizophrenia.
This study has finished and is no longer accepting participants.
In TaipeiSchizophreniaMedication studyAges 20–65
- Countries
- Taiwan
- Sponsor
- Tri-Service General Hospital (TSGH)
CompletedNCT05517460
This study has finished and is no longer accepting participants.
In Taipei CountySchizophreniaInterventional studyAges 40+
- Countries
- Taiwan
- Sponsor
- Taipei Medical University